In the most recent study, an immunotoxin composed of an anti-Glypican-3 (GPC3) antibody and Pseudomonas aeruginosa exotoxin A (PE38) was designed for the treatment of SCLC and liver cancer. The gene discussed is GPC3; the disease is liver cancer.